Application 125399
- Type
- BLA
- Sponsor
- SEATTLE GENETICS
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125399 | Adcetris | brentuximab vedotin | 351(a) | Rx | 2021-02-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ADCETRIS | BRENTUXIMAB VEDOTIN | INJECTABLE; INJECTION | 50MG/VIAL | No | No |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ADCETRIS | BRENTUXIMAB VEDOTIN | SEAGEN INC. | 3904f8dd-1aef-3490-e48f-bd55f32ed67f | 2025-11-11 | Boxed warning, Warnings, Adverse reactions | ADCETRIS BRENTUXIMAB VEDOTIN |